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INTRODUCTION 
Schizophrenia is a chronic, disabling disorder for most affected 
individuals. Despite historical pessimism about prognosis, more recent studies 
suggest that early intervention can improve outcome. Efforts at early 
identification and treatment are based in part on the assumption that through an 
as- yet unknown process, illness duration causally influences treatment 
responsivity and outcome. 
A large number of studies have examined the prognostic value of 
premorbid, sociodemographic, and psycho- pathological factors on outcome in 
schizophrenia.More recently, several groups of investigators have proposed 
that a long duration of untreated initial psychosis may also affect long- term 
outcome in schizophrenia. 
Wyatt was the first to suggest that psychosis may be “biologically toxic” 
and that long-term morbidity in some patients with schizophrenia may be 
prevented if patients are treated with neuroleptics 
Some investigators have found an association between longer duration 
of untreated initial psychosis and poor outcome in schizophrenia and have 
explained such an association with the “toxic psychosis” hypothesis. 
Understanding the causes and consequences of untreated psychosis is 
important for at least two reasons.  First, the duration of untreated psychosis  
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(DUP) is a potentially modifiable prognostic factor, and understanding its 
relation to outcome could lead to improved therapeutic strategies and public 
health initiatives. Second, a relationship of duration of untreated psychosis to 
outcome may indicate a neurodegenerative process and so have important 
implications for understanding the pathophysiology of schizophrenia. 
Alternatively, the length of initially untreated psychosis may be related 
to the severity of illness and thus may be a marker rather than a determinant of 
outcome. 
However, despite the knowledge of such factors, the prediction of 
outcome in schizophrenia has remained a challenging task and is generally 
poor. One of the well established facts and consistent finding about outcome of 
schizophrenia is that patients from developing countries including India have 
better outcomes than those from the developed countries (Lieberman, 1996). 
Though there is no definitive evidence as to whether reduction of DUP 
will alter the course of schizophrenia for better, this issue has considerable 
public health importance. Given the low psychiatrist to population ratio and 
difficulties in reaching a psychiatrist, it is unlikely that patients from 
developing countries have shorter DUP than those from the developed 
countries. 
There is a need to study the influence of duration of untreated psychosis 
on outcome of schizophrenia in the Indian context, hence this study. 
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REVIEW OF LITERATURE 
Schizophrenia has been with us as an identified illness for over a 
century. Kraeplin described it as ‘dementia praecox’ in 1896 separating it from 
the broad spectrum of psychoses seen within his clinic, and Bleuler renamed it 
as schizophrenia in 1908. Illness are usually identified and defined in terms of 
their clinical presentation, course and outcome. 
Kraeplin’s identification of what we now call as schizophrenia rested 
almost exclusively on course and outcome. He found a very pessimistic view of 
the outcome in schizophrenia, and was convinced that recovery was very rare, 
or even impossible, and deterioration almost inevitable. 
Kraeplin’s gloomy appraisal of the outcome has been challenged, most 
convincingly by careful follow-up studies. 
Some of the commonly measured outcomes in schizophrenia are 
symptom outcomes, cognitive and neurobiological outcomes, patient related 
outcomes, adverse drug effects, social outcomes, hospitalization, duration of 
untreated psychoses and economic outcomes. 
Duration of untreated psychoses: 
In the past two decades, duration of untreated psychoses(DUP) has been 
an intense focus of clinical and research interest, with the recognition that not 
only is long DUP associated with poor outcome, but that as a potentially 
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malleable prognostic factor, reducing it at the population level might have a 
significant public health importance(Swaran&Singh et al 2007). 
Angst and Schulz reviewed 10 studies performed in the 1950s that 
studied both acute and chronic patients who had not received drug treatment. 
Poorer response to neuroleptics was found among chronic patients in six 
studies, suggesting that delay in treatment may lead to a significantly poor 
outcome. 
Lo Lo et al (1977) in a retrospective 10 year follow-up study of 133 
chronic schizophrenic patients found that shorter duration of untreated illness 
prior to the initial acute episode was significantly associated with favorable 
outcome. 
By the 1980s, studies had begun to demonstrate the importance of the 
time period between the onset of psychoses and initiating treatment in 
determining outcome in schizophrenia. 
May et al in 1981 randomly assigned 228 first admission schizophrenic 
patients to five treatment groups, three of which did not include drug treatment 
(psychotherapy, milieu therapy and ECT group). Patients from the above three 
groups who did not respond were subsequently treated with antipsychotic 
drugs. In this study the drug treatment groups showed the best response and, 
together with ECT group showed the best outcome for up to three years (as 
measured by clinical, social and psychological criteria). Thus the groups 
 5
initially not treated with medication were found to have a poor outcome over 
the following period.  
Inoue et al (1986) in a retrospective evaluation of 19 treated 
schizophrenic and schizophreniform patients noted that the time interval 
between onset of illness and first outpatient treatment varied from 1 to 6 years. 
Less favorable outcome in the form of poor occupational and scholastic 
achievement at 3year follow up was predicted by long duration of illness (4 
years or more).   
Rabiner et al in 1986 studied a group of 64 first episode subjects with 
varied diagnosis and found that 36 schizophrenic subjects had a mean duration 
of illness of 14.5months. This study also found that the longer the  duration of 
illness, the poorer the outcome, as measured by the presence of remission or 
relapse over a 1 year follow up period. 
In a prospective study of 120 first episode schizophrenic patients who 
were followed up for 2 years in a randomized controlled trial of maintenance 
neuroleptic treatment, relapse subsequent to initial hospital discharge was 
substantially more common in those whose pretreatment illness lasted more 
than 1 year. Only 18% of the patients who were given active treatment and 
none who were given placebo remained free of relapse after 2 years (Crow et 
al). 
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The Northwick Park study of first-episode of schizophrenia found that 
the most important determinant of relapse was duration of illness prior to 
starting antipsychotics (John stone et al 1986). 
Wyatt has shown that patients who had not been treated with 
neuroleptics and who were discharged within six months of hospitalization 
required significantly more rehospitalization and as much subsequent 
neuroleptic treatment as patients who had neuroleptics. 
Loebel et al (1992) did a year 3 year prospective study in 70 
schizophrenic patients and found that the mean duration of psychotic symptoms 
before initial treatment was 52 weeks. The effect of duration of illness was 
found to be significantly associated with time to remission as well as with level 
to remission .DUP was not correlated with age at onset, mode of onset, 
premorbid adjustment or severity of illness at entry into the study. 
Haas et al in 1998 in his prospective study of 103 schizophrenia patients 
found that those with one or more years of untreated psychoses displayed a 
more severe poverty syndrome at the time of admission and discharge and a 
more severe reality distortion syndrome at discharge from index 
hospitalization, thus concluding that failure to initiate treatment early in the 
course of illness may be associated with a recurrent pattern of poor treatment 
response and more severe and persistent positive and negative 
symptomatology.  
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In the West London first episode study of schizophrenia   by Barnes et al 
in 2000, there was little evidence of any association between DUP and 
progressive deterioration in schizophrenic illness. Patients in the long DUP 
(>26 weeks) were more likely to be employed and living alone or homeless. 
Drake et al in 2000, did a 12 month follow up study in 248 consecutive 
first admissions with schizophrenia, and found that median DUP was 12 weeks. 
Long DUP was predicted by poor insight, social isolation and preserved coping 
skills, but not by demographic factors. Even allowing for these for variables, 
long DUP predicted poor outcome. He thus concluded that DUP’s relationship 
to outcome is strongest in the initial months of psychoses. 
Beng and Andreasen et al in 2000 evaluated 74 neuroleptic-naïve 
schizophrenic patients for 6 months and found that earlier age at illness onset 
was associated with long duration of untreated prodromal psychotic symptoms. 
After controlling the effect of age at onset, the DUP did not significantly impair 
subsequent the quality of life, symptom severity, or remission of positive 
symptoms. 
In the above mentioned study, there were no significant association 
between DUP and premorbid functioning, nor were there any significant 
gender differences in DUP. 
A two year follow-up study of 65 first admitted subjects with psychoses 
had found that the association between DUP and poor outcome may be 
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spurious; confounded by the fact that poor premorbid functioning is 
independently associated with both DUP and poor outcome, with no direct 
causal link between these two later variables (Verdoux et al). 
Craig and his colleagues in 2000 did a 24 month follow-up study in first 
admission schizophrenic in-patients and found that the median duration of 
untreated psychoses was 98 days and duration of untreated psychoses was not 
significantly associated with 24-month illness course or clinical outcome.   
Harris et al (2005) in a prospective, naturalistic study of 318 first 
episode psychoses patients found that shorter DUP correlated moderately with 
decreased severity of positive symptoms, and enhanced social and occupational 
functioning and quality of life. DUP exceeding 1 year was associated with a 
poor outcome and there was no association with DUP and negative symptoms. 
In a systematic review of 26 first-episode studies, Marshall et al in 2005 
found that a longer DUP was not associated with worse symptoms or poorer 
functioning at first presentation, at 6 and 12 months following treatment. 
Longer DUP was associated with more severe overall symptoms and with 
worse overall functioning. Patients with long DUP were also less likely to 
experience remission at 6, 12, and 24 months. 
Perkins et al did a review of 43 studies and found that longer DUP was 
associated with more severe negative but not positive symptoms or 
neurocognitive functioning, shorter duration of untreated psychoses was thus 
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associated not only with greater treatment responsiveness but also with greater 
reduction in negative symptoms. 
Norman and his colleagues did a systematic review and found that there 
is a substantial evidence of DUP being an independent predictor of treatment 
outcome, particularly remission of positive symptoms, over the first year or so 
of treatment. 
Indian studies on Duration of untreated psychoses and outcome: 
Studies from the West have shown that the duration of untreated 
psychoses is associated with poor outcome, with the relationship being 
strongest in the initial months of psychoses. This is particularly relevant in low- 
and middle income countries where a significant number of patients come late 
to treatment. 
The reasons for delay in treatment were due to lack of awareness, a 
strong belief in magical or religious causes, poor accessibility to health care 
systems and lack of community care (Isaac et al, 1981; Padmavathi et al, 1991). 
A cross-cultural study on pathways to psychiatric care replicated these 
findings (Gater et al 1991). Most patients are brought for treatment after a 
significant delay from the onset of symptoms. 
Philip et al in 2003 did a study on the influence of duration of untreated 
psychosis on the short term outcome of drug-free schizophrenic patients and 
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found that DUP was longer in the unimproved group. In a logistic regression 
model, only DUP emerged as a significant predictor. 
Tirupati et al in 2004 did a prospective follow-up study of 75 drug naïve 
patients out of which 60% had a DUP of over 5 years and 36% over 12 years. 
Following treatment for one year, patients with a DUP of 5 years or less had 
shown good clinical outcome. An encouraging observation was the notable 
treatment response despite many years of untreated illness. 
Isaac et al in 2007 have described factors apparently contributing to 
good prognosis of schizophrenia in low-and middle-income countries. 
Established 
¾ Less expressed emotion 
¾ Good social support 
¾ Tolerance of odd behavior by society and family 
¾ Marriage 
Doubtful 
¾ Less industrialization and urbanization 
¾ Early death of those with bad outcome 
¾ Increased prevalence of acute psychosis 
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Needs to be established 
¾ Co morbid substance use 
¾ Duration of untreated psychosis 
¾ Pharmacological interventions  
Can duration of untreated psychosis be reliably measured? 
Onset of psychosis is a nebulous phenomenon that evades close 
scrutiny. Establishing onset has become important for early identification and 
intervention of psychosis. Yet there is no consensus definition of onset of 
psychosis and the literature yields few standardized replicable methods for 
measuring onset (Singh et al, 2005). 
Clinically it is difficult to identify a precise time when a certain behavior 
or symptom makes the transition from non-psychotic to a psychotic domain, 
with considerable arbitrariness introduced in both identifying and dating the 
phenomenon.  
Definitions of onset thus vary from the interval between first sign of 
illness and the appearance of florid psychotic symptoms (Valliant, 1964) to the 
interval between appearance of psychotic symptoms to the initiation of 
treatment (Day et al 1987). 
The end of the period of untreated psychosis is conceptually simpler to 
date, but ‘the start of treatment’ is in a reality a similarly complex construct. 
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Does ‘untreated psychosis’ end when any treatment begins, when anti-
psychotics are started, treatment at an adequate dose has been adhered for an 
adequate period, or when psychosis itself remits? Many studies do not make 
these distinctions clear in their measure of DUP and scales do not include a 
precise definition of treatment adequacy. 
The Nottingham Onset Schedule is a short, guided interview and rating 
schedule to measure onset in psychosis. Onset is defined as the time between 
the first reported/observed change in mental state/behavior and the 
development of psychotic symptoms (Singh et al 2005). 
Marshall et al (2005) in his systematic review found that only 12 out of 
26 studies reported a systematic method to assess DUP.   
Confounding factors associated with DUP 
It is important to examine whether any relationship that does exist 
between duration of untreated psychosis can be explained by other confounding 
factors which have in the past been found to predict treatment outcome. 
Gender 
Loebel et al (1992) and Larsen et al (1996) report that males have a long 
duration of untreated psychosis than females. Five other studies do not find any 
gender differences to be associated with DUP. 
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Age at onset: 
Ho et al (2000) in his follow-up study has found that longer DUP was 
significantly related to younger age at onset of illness while many other studies 
do not show any such difference (Haas et al, Loebel et al, Larsen et al,  
Blake et al). 
Symptoms at baseline 
Several studies have reported longer DUP to be associated with higher 
levels of at least some aspects of negative or deficit symptoms at presentation 
(Larsen et al, Browne et al, Malla et al, Blake et al). DUP was associated with 
the severity of negative symptoms but not with the severity of positive 
symptoms or general psychopathology. (Perkins et al). 
Drake et al (2000) found a relationship between longer DUP and higher 
positive but not negative symptoms at presentation, but others have found no 
relation to initial positive symptoms (Larsen et al, Malla et al). 
Premorbid adjustment 
The interpretation of findings with respect to premorbid adjustment as a 
possible explanation for any relation between DUP and treatment outcome is 
potentially complex. Harrigan et al (2003) demonstrated that in a large sample 
of patients with first-psychosis, the effects of DUP on several dimensions of 
outcome are independent of premorbid adjustment prior to the onset of 
 14
prodromal or psychotic symptoms. DUP remained as a significant predictor of 
outcome at 12 months following a multiple regression analysis that included 
premorbid adjustment. 
Very few studies have found lower premorbid adjustment to be 
significantly associated with longer duration of untreated psychosis (Verdoux 
et al, Malla et al). Poor premorbid function could confound the relationship 
between DUP and outcome, because both could lead to delays in recognizing 
illness.  
In a 10 year follow-up study by White et al, he found that both 
premorbid adjustment and DUP to be independent predictors of symptomatic 
and functional outcomes. 
Treatment response 
Shorter duration of untreated psychosis was associated with a greater 
response to antipsychotic treatment as measured by improvement or end point 
severity of symptoms.( Perkins et al). 
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Studies examining the relationship between duration of untreated psychosis 
and outcome 
Associated with poor outcome       Not associated with poor    
                                                        Outcome 
Johnstone et al (1086)                     Linszen et al (1998) 
Makanjoula et al (1087)                  Craig et al (2000) 
Helgason et al (1990)                      Ho et al (2000) 
Moscarelli et al (1991)                    de Haan et al (2000) 
Loebel et al (1992)                          Barnes et al (2000) 
Waddington et al (1995) 
Wyatt et al (1997) 
Scully et al (1997) 
Haas et al (1998) 
Carbone et al (1999) 
Larsen et al (2000) 
Drake et al (2000) 
Browne et al (2000) 
Harris et al (2003) 
Philip et al (2003) 
Tirupati et al (2004) 
Marshall et al (2005) 
Perkins et al (2005)      
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AIMS AND OBJECTIVES 
1.  To study the clinical and social determinants of duration of untreated 
psychosis in drug naïve schizophrenic patients. 
2.  To assess the influence of duration of untreated psychosis on the short-
term outcome in schizophrenia. 
3.  To study the relationship of premorbid social adjustment on the duration 
of untreated psychosis and outcome. 
 17
HYPOTHESIS 
1) There is no significant association between duration of                       
untreated psychosis and age, gender. 
2) There is no significant correlation of marital status, occupational status 
and socioeconomic status with duration of untreated psychosis. 
3) There is no significant association of duration of untreated psychosis 
and the mode of onset. 
4) There is no significant association between duration of untreated 
psychosis and the type of family. 
5) There is no significant association of duration of untreated psychosis 
and the severity of symptoms at baseline. 
6) There is no significant association between the improved and the 
unimproved groups with regard to the sociodemographic variables. 
7) There is no significant association between improved and unimproved 
groups in terms of the duration of untreated psychosis. 
8) There is no significant association of premorbid social adjustment and 
duration of untreated psychosis and outcome at 8 weeks. 
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MATERIALS AND METHODS 
This study was done at The Institute of Mental Health, Chennai. 
SAMPLE 
100 consecutive patients admitted as in-patients in the institute of mental 
health, fulfilling the ICD-10 criteria for schizophrenia, who were never treated 
were included in the study. 
INCLUSION CRITREIA 
1.  Age 18-45 years. 
2.  Patients with a diagnosis of schizophrenia as per ICD-10 criteria. 
3.        Drug naïve patients. 
EXCLUSION CRITERIA: 
1.  A medical condition that might influence the current state of psychiatric 
presentation. 
2.  History of head injury 
3.  Current substance use disorder or history of substance dependence 
disorder. 
4.  Mental retardation  
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MATERIALS USED 
1.  Semi-structured proforma. 
2.  SAPS (Scale for assessment for positive symptoms) 
3.  SANS (Scale for assessment of negative symptoms) 
4.  Clinical Global Impression –Schizophrenia Scale(CGI-SCH) 
5.  Global assessment of functioning (GAF) 
6.  Premorbid Social Adjustment Scale (PSA)   
A Semi-structured Proforma to include the socio-demographic and 
clinical data, family history, subtypes of schizophrenia, treatment, 
hospitalization.( Appendix I) 
Clinical interview for diagnosis of ICD-10 criteria for schizophrenia. 
Ascertainment of Duration of untreated psychosis 
Data relating to the onset of psychosis were collated from interviews 
with the patient and a close relative of the patient. After explaining psychosis in 
clear language, we asked when the patient first experienced or when the family 
members first noticed psychotic symptoms. 
In line with the previous studies (Craig et al, 2000 and Morgan et al, 
2006), onset of psychosis defined as the presence for 1 week or more of the 
following psychotic symptoms: delusions; hallucinations; marked thought 
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disorder; marked psychomotor disorder; and bizarre, grossly inappropriate 
and/or disorganized behavior with a marked deterioration in function. A rating 
of onset was made only when there was a clear, unequivocal description from 
any source of symptoms meeting the criteria. In this study the end point was 
considered as admission to the hospital. 
SAPS (Scale for the Assessment of positive Symptoms) and SANS 
(Scale for the Assessment of negative symptoms) were used. These scales 
were sourced from the University of Iowa press, 1983. These scales are used 
for the assessment of positive and negative symptoms, principally those 
occurring in schizophrenia. Both the instruments are used in a way 
complimentary to each other. They have been widely used in many studies and 
well tested for reliability and validity. The SAPS contains 35 items divided into 
5 domains i.e. Hallucinations, Delusions, Bizarre behavior, Positive formal 
thought disorder and inappropriate affect. The SANS contains 24 items divided 
into 5 domains i.e. Affective flattening or blunting, Alogia, Avolition-apathy, 
Anhedonia-asociality and Attention. Items in both the scales are scored 
between 0 (none) and 5 (severe).   
Three dimensions were used to summarize symptom severity, based on 
previous studies. The negative symptom dimension was defined as the sum of 
the global ratings of alogia, anhedonia, avolition and affective flattening 
(range=0-20). The psychotic symptom dimension was defined as the sum of the 
global ratings of delusions and hallucinations (range=0-10). The disorganized 
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symptom dimension was the sum of the global ratings of bizarre (disorganized) 
behavior, positive thought disorder, and inappropriate affect (range=0-15). 
Higher scores represent greater symptom severity.(Appendix II & III). 
Clinical Global Impression-Schizophrenia scale: (CGI-SCH) 
This Scale was adapted from the CGI scale and the CGI-bipolar Patients 
scale by Haro et al in 2003. This scale is a reliable and a valid instrument to 
evaluate severity and treatment response in schizophrenia. It consists of only 2 
categories; severity of illness and the degree of change. The severity of illness 
category evaluates the situation during the week previous to the assessment, 
while the degree of change category evaluates the change from previous 
evaluation. Each category contains five different ratings (positive, negative, 
depressive, cognitive and global) that are evaluated using a seven point ordinal 
scale. (Appendix IV ) 
The Premorbid Social Adjustment Scale 
This scale was an adapted version of the cannon-spoor scale (1992), was 
used to assess five areas of adjustment; sociability, peer relations; scholastic 
performance; adaptation to school and interests. Each subject received a score 
for each item, rated on a 7 point Likert scale that Ranged from 1 (excellent 
adaptation) to 7 (extremely poor adaptation). Each item was rated separately 
for childhood (5-11 years) and adolescence (12-16 years). The total Premorbid 
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Adjustment Scale score is obtained by summing up the two sub scores. Higher 
scores indicate poorer premorbid functioning. (Appendix V) 
Global Assessment of Functioning Scale: (GAF) 
The GAF scale is used to assess psychiatric patients at the time of 
admission to an inpatient or an outpatient program as part of the multiaxial 
evaluation recommended by the APA DSM classifications. The GAF scale is a 
100-point single-item scale with values ranging from 1 to 100 representing the 
hypothetically sickest person to the healthiest. The scale is divided into 10 
equal 10-point intervals with the 81 to 90 and 91 to 100 intervals for 
individuals who exhibit superior functioning. The 71 to 80 interval is for 
persons with minimal psychopathology. Most patients in outpatient settings 
will receive ratings between 31 and 70, and most inpatients between 1 and 40. 
(Appendix VI) 
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METHOD 
Consecutive patients fulfilling the ICD-10 criteria for schizophrenia, 
admitted as inpatients in the Institute of Mental Health, Chennai from June 
2006 to August 2006 were evaluated. Those satisfying the inclusion and 
exclusion criteria were taken into the study. The diagnosis was obtained from 
the case records and re-confirmed by 2 psychiatrists, one of them a senior 
consultant. 
Informed consent in a written form was obtained for participation in the 
study from the patients as well as the relatives.  
The patients were administered the Semi-structured proforma, Scale for 
the Assessment of Positive Symptoms (SAPS), Scale for Assessment of 
Negative symptoms (SANS), Clinical Global Impression-Schizophrenia Scale, 
Global Assessment of Functioning Scale (GAF) and the Premorbid Social 
Adjustment Scale at the time of admission or within few days. Treatment in the 
ward was given by a psychiatrist in charge of the ward according to the 
patient’s symptoms and needs. The treating psychiatrist was completely blind 
to the study sample. 
Follow up assessment was done after a period of 8 weeks by 
administering SAPS, SANS and GAF. All those who completed 8 weeks of 
follow-up were enquired from their caregivers about compliance to medication. 
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The outcome was assessed using the Clinical Global Impression-
schizophrenia scale and GAF. The outcome variable was converted into 
dichotomous, unimproved (>4 on CGI-SCH scale which includes no change, 
minimally worse, much worse and very much worse; GAF>60) and improved 
(<3 on CGI-SCH scale which includes minimally improved, much improved 
and very much improved; GAF<60). 
The data collected thus were tabulated and discussed with reference to 
the aims and objectives of the study. Statistical analysis was done using the chi-
square test, t-test and correlation methods. In measuring DUP there is more 
chances of right skew, hence after initial data analysis DUP was normalized by 
taking the logarithm to base 10 (log DUP) to allow the use of parametric 
statistics (Pearson’s r, t-tests) and these results were presented. Data was 
analyzed using SPSS 11.0. P< 0.05 is considered as a statistically significant 
value. 
Approval was obtained from the Ethics committee of the Institute of 
Mental Health, Chennai. 
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RESULTS 
100 consecutive patients were screened, evaluated and entered into the 
study out of which 3 patients were excluded, one patient was found to be HIV 
positive and 2 patients were found missing from the ward. Hence the total 
number of sample at baseline assessment was 97. At the end of 8 weeks follow 
up assessment was done for 63 patients who reported along with their 
caregivers. The remaining 34 patients who did not complete the follow up were 
categorized as ‘non-completers’.  
  
Total No. of Patients at Baseline ( n = 97)  
 
 
Non-completers    Completers 
     (n=34)         (n=63)  
 
 
       Improved    Unimproved 
  (n=41)       (n=22) 
 
Sample characteristics at admission: (n=97) 
The baseline sample included 97 patients among which 43 (44.3%) were 
men and 54(55.67) were women. Mean age of the patients was 29.7(6.7) years. 
More than 90% of the patients were in the low and middle socioeconomic 
status. 
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11.34% were uneducated, 24.74% up to primary school, 35.05% in high 
school, 13.4% up to higher secondary level and 15.4% were graduates. 
39(40.2%) patients were married, 8(8.2%) were married and separated, 1patient 
was a divorcee, 4 patients were widowed and 45(46.3%) were unmarried. 
66(68.1%) patients were in a joint family system and 31(31.9%) were in the 
nuclear type of family. 69.1% were employed and 30.1% were unemployed 
among the sample.  
Age at onset of illness was 27.94 ± 6.2 years. The mean duration of 
untreated psychosis was 22.33 ± 28.8 months. 40(41.2%) patients had a DUP 
between 1-6 months, 17(17.5%) between 6-12 months, 3(3.1%) had a duration 
between 13-18 months, 4 patients between 19-24 months and 33(34.1%) had a 
DUP greater than 2 years (Table 1). 
Family history of schizophrenia was present in 31(31.9%) patients and 
there was no such illness in 66(68.1) patients. 
TABLE NO. 1  
 
DURATION OF UNTREATED PSYCHOSIS OF THE  
WHOLE SAMPLE (N = 97) 
 
DUP (Months) Frequency Percentage 
1 – 6 Months 40 41.24% 
7 – 12 Months 17 17.53% 
13 – 18 Months 3 3.09% 
19 – 24 Months 4 4.12% 
> 24 Months 33 34.02% 
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TABLE NO. 2 
CORRELATION OF DURATION OF UNTREATED PSYCHOSIS 
WITH AGE AT FIRST PRESENTATION AND AGE AT ONSET OF 
ILLNESS 
DUP (Months) Correlation coefficient P 
Age 0.346 0.001 
Age at Onset 0.003 0.971 
 
There is a positive correlation between the age at first presentation and 
the duration of untreated psychosis with the p value being significant (P< .05). 
There is no significant correlation between DUP and the age at onset of illness. 
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TABLE NO. 3 
CORRELATION OF SYMPTOMS AND PREMORBID  
FUNCTIONING WITH DUP 
Log DUP Correlation Coefficient p Value 
Psychotic domain 0.021 0.838 
Disorganized 0.192 0.061 
Negative 0.256 0.011 
Premorbid social Adjustment score 
(Total) 
0.334 0.001 
 
The correlation of logDUP with psychotic and disorganized symptom 
domain was non significant (P> .05). There is a significant correlation between 
DUP and negative symptom domain at baseline presentation (P< .05). 
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FIG. 1 COMPARISON BETWEEN PATIENTS WHO COMPLETED 
FOLLOW UP AND NON-COMPLETERS.
Completed 
65%
Not Completed
35%
 
The total number of patients who completed 8 weeks of follow up and 
who were regular on medication were categorized as ‘completers’. Those who 
did not turn for follow up were categorized as ‘non-completers’. There was no 
statistically significant difference among the socio-demographic and clinical 
variables. No significant difference was found between the two groups with 
regard to the duration of untreated psychosis, symptom domains and premorbid 
functioning (Table 4). 
 30
 
 
 
TABLE NO. 4 
COMPARISON OF THOSE WHO COMPLETED 8 WEEKS OF 
FOLLOW-UP WITH NON-COMPLETERS 
Variables Completed n = 63 
Non-
Completers 
n = 34 
p 
Age 30.20 ± 6.8 29.02 ± 6.6 1.43 
Age at onset 28.11 ± 6.3 27.61 ± 6.1 0.71 
Psychoticism 3.76 ± 2.1 3.23 ± 1.7 0.22 
Disorganization 3.22 ± 2.4 2.64 ± 1.7 0.23 
Negative 2.52 ± 3.5 3.11 ± 3.4 0.42 
Premorbid Social Adjustment 27.88 ± 7.1 27.52 ± 4.8 0.79 
Log DUP 1.05 ± 0.55 1.02 ± 0.48 0.73 
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TABLE.NO.5 
GENDER WISE COMPARISON BETWEEN IMPROVED AND 
UNIMPROVED GROUPS 
Improved Unimproved 
Gender 
n % n % 
Total 
Male 21 51.2 11 50.0 32 
Female 20 48.8 11 50.0 31 
Total 63 100 22 100 63 
                                                                                         χ2 = 0.008 p=0.92 
Among the improved group of patients, 51.2% were males and 48.8% 
were females. In the unimproved group 50% were males and 50% were 
females. The difference was not statistically significant.  
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FIGURE 2 
GENDER WISE COMPARISON BETWEEN IMPROVED AND 
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TABLE.NO.6 
COMPARISON OF THE GROUPS BY EDUCATION 
Improved Unimproved 
Education 
n % n % 
Total 
Uneducated  5 12.2 3 13.6 8 
Primary 10 24.4 7 31.8 17 
Secondary 12 29.3 6 27.3 18 
High school 3 7.3 4 18.2 7 
Graduate  11 26.8 2 9.1 13 
Total 41 100 22 100 63 
  χ2 = 4.04 p = 0.40 
Among the improved group, 12.2% were uneducated, 24.4% were 
educated upto primary level, 29.3% upto secondary level, 7.3% upto high 
school and 26.8% were graduates. In the unimproved group, 13.6% were 
uneducated, 31.8% were educated upto primary level, 27.3% upto secondary 
level, 18.2% upto high school and 9.1% were graduates. The difference was not 
statistically significant. 
 
 
 34
 
 
 
FIG. 3 COMPARISON OF THE GROUPS BY EDUCATION  
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TABLE NO. 7 
COMPARISON OF THE GROUPS BY SOCIO ECONOMIC STATUS 
Improved Unimproved SE 
status n % n % 
Total 
Low 34 82.9 16 72.7 50 
Middle 6 14.7 5 22.8 11 
High 1 2.4 1 4.5 2 
Total 41 100 22 100 63 
                                                                                        χ2 1.07  p=0.59 
In the improved group 82.9% were from lower socioeconomic group, 
14.7% were from middle socio-economic group and 2.4% belonged to higher 
socio-economic group. In the unimproved group 72.7% were from the lower 
socio-economic group, 22.8% were from the middle socio-economic group and 
4.5% belonged to higher socioeconomic group. The difference was not 
statistically significant. As our study was done at a government institute, 
majority of the individual were from the lower socio-economic class.  
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 FIG. 4 COMPARISON OF THE GROUPS BY SOCIO  
ECONOMIC STATUS  
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TABLE NO. 8 
COMPARISON OF THE GROUPS BY OCCUPATION 
Improved Unimproved 
Employment  
n % n % 
Total 
Employed 10 24.4 6 27.3 16 
Unemployed 31 75.6 16 72.7 47 
Total 41 100 22 100 100 
                                                   χ2 = 0.062  p=0.802 
Out of the improved group, 24.4% were employed and 75.6% were 
unemployed. In the unimproved group 27.3% were employed and 72.7% were 
unemployed. The difference was not statistically significant.  
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FIG. 5 COMPARISON OF THE GROUPS BY OCCUPATION  
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TABLE NO. 9 
COMPARISON OF THE GROUPS BY MARITAL STATUS 
Improved Unimproved 
Marital status 
n % n % 
Total 
Married 16 39.0 9 40.9 25 
Married and separated 3 7.3 1 4.5 4 
Divorced  0 - 0 - 0 
Widow 2 4.9 1 4.5 3 
Unmarried 20. 38.8 11 50.0 31 
Total 41 100 22 100 63 
                                                                                           χ2 = 0.193 p=0.97 
In the improved group 39% were married, 7.3% separated, 4.9% were 
widowed and 38.8% were unmarried. In the unimproved group 40.9% were 
married, 4.5% were separated, 4.5% were widowed and 50% were unmarried. 
The difference was not statistically significant. 
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FIG.6 COMPARISON OF THE GROUPS BY MARITAL STATUS  
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TABLE NO. 10 
 COMPARISON OF THE GROUPS - TYPE OF FAMILY AND FAMILY 
HISTORY OF SCHIZOPHRENIA 
Variable Improved (n=41) 
Unimproved 
(n=22) χ
2 P 
Type of family (%)   
Joint 
Nuclear 
 
75.6% 
24.47% 
 
72.7% 
27.3% 
 
0.02 
 
0.88 
Family history of 
schizophrenia 
Yes 
No 
 
 
26.8% 
73.2% 
 
 
27.3% 
72.7% 
 
 
0.01 
 
 
0.96 
 
In the improved group 75.6% belonged to joint family system and 
24.4% belonged to nuclear family. In the unimproved group 72.7% belonged to 
joint family, while 27.3% belonged to nuclear family. The difference was not 
statistically significant. 
Family history suggestive of schizophrenic illness was present in 26.8% 
among the improved group and in 27.3% among the unimproved group, the 
difference being statistically insignificant. 
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TABLE NO. 11 
COMPARISON OF GROUPS BY DIAGNOSIS 
Improved Unimproved 
Diagnosis  
n % n % 
Total 
Paranoid  24 58.5 8 36.4 32 
Hebephrenic 1 2.4 1 4.5 2 
Catatonic 1 2.4 0 - 1 
Undifferentiated  15 36.6 13 59.1 28 
Total 41 100 22 100 63 
                                  χ2=3.75 p=0.28 
Among the improved group of patients, 58.5% were paranoid subtype, 
2.4% were hebephrenic type, 2.4% were catatonic type and 36.6% were of 
undifferentiated subtype. In the unimproved group 36.4% were paranoid type, 
4.5% were hebephrenic type and 59.1% were of undifferentiated subtype. The 
difference was not statistically significant. 
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FIG.7 COMPARISON OF GROUPS BY DIAGNOSIS  
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TABLE NO. 12 
COMPARISON OF THE GROUPS - HOSPITALIZATION 
Improved Unimproved Hospitalization 
(days) n % n % 
Total 
<7 days 22 53.7 8 36.4 30 
8-14 days 17 41.5 8 36.4 25 
15-21 days 1 2.4 4 18.2 5 
22-28 days 1 2.4 2 9.1 3 
Total 41 100 22 100 63 
                                                                                            χ2=6.79 p=0.78 
In the improved group 53.7% were hospitalized for less than a week, 
41.5% between 8-14 days, 2.4% between 15-21 days and 22-28 days. In the 
unimproved group 36.4% were hospitalized for less than a week and between 
8-14 days, 18.2% between 15-21 days and 9.1% between 22-28 days. The 
difference between the groups was not statistically significant. 
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TABLE NO. 13 
COMPARISON OF THE GROUPS - AGE AT PRESENTATION AND 
THE AGE AT ONSET OF ILLNESS 
Variable Improved n=41 
Unimproved
n=22 t value P 
Age at presentation 
(months) 
29.41 ± 6.4 
(Mean ± SD) 
31.68 ± 7.3 1.26 0.212 
Age at onset 
(months) 
28.02 ± 5.9 28.27 ± 7.1 0.15 0.88 
 
Mean age at first presentation was 29.41 months for the improved group 
and 31.68 for the unimproved group, the difference being statistically 
insignificant. Age at onset of illness was 28.02 among the improved group and 
28.27 for the unimproved group. The difference was not statistically 
significant. 
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TABLE NO. 13 
COMPARISON OF THE GROUPS BY SYMPTOM SEVERITY 
Symptoms 
Improved 
(n=41) 
Unimproved 
(n=22)  
Mean ± SD 
t value p 
Psychoticism 3.92 ± 1.9 3.45 ± 2.5 0.83 0.409 
Disorganization 2.85 ± 2.2 3.90 ± 2.6 1.65 0.104 
Negative 1.56 ± 2.8 4.31 ± 3.9 3.16 0.002 
 
The score on psychotic symptom domain was 3.92 ±1.9 for the 
improved group and 3.45± 2.5 for the unimproved group, the score on 
disorganization domain was 2.85 ±2.2 for the improved group and 3.9 ±2.6 for 
the unimproved group. The difference was not statistically significant for both 
the above domains. In the improved group the score on negative symptom 
domain was 1.56 ±2.8 and 4.31±3.1 for the unimproved group and the 
difference between the two groups was statistically significant (P< .05). 
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FIG. 8 COMPARISON OF THE GROUPS BY SYMPTOM SEVERITY  
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TABLE NO. 14 
COMPARISON OF THE TWO GROUPS ON DURATION OF 
UNTREATED PSYCHOSIS 
Variable 
Improved  
n=41 
Mean ± SD 
Unimproved
n=22 
Mean ± SD 
t value P 
Log DUP 0.898 ± 0.5 1.357 ± 0.5 3.41 0.001 
 
In the improved group the duration of untreated psychosis was 
0.898±0.5 (logDUP), the corresponding DUP in months being 7.92 months and 
in the unimproved group the duration of untreated psychosis was 1.36±0.5 
(logDUP), the corresponding DUP in months was 22.78. The difference 
between the two groups was statistically significant. 
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TABLE NO. 15 
COMPARISON OF THE GROUPS ON PREMORBID FUNCTIONING 
Variable Improved 
n = 41 
Unimproved 
n = 22 
T value p 
Premorbid social 
adjustment (Total 
Score) 
25.78 ± 6.8 31.81 ± 2.5 3.54 0.001 
 
In the improved group the premorbid social adjustment score was 
25.78±6.8 and the score in the unimproved group was 31.81±2.5. The 
difference between the two groups was statistically significant.  
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TABLE NO. 16 
COMPARISON OF THE TWO GROUPS BY MODE OF TREATMENT  
Improved Un Improved 
Mode of Treatment 
n % n % 
Total 
Typical drugs 2 4.9 - - 2 
Atypical 32 78.0 12 54.5 44 
ECT & Drugs 7 17.1 10 45.5 17 
Total 41 100 22 100 63 
                                  χ2 = 6.44 p = 0.03 
In the improved group 4.9% were treated with typical antipsychotic 
drugs, 78% with atypical drugs, 17.1% with ECT and drugs. In the unimproved 
group 54.5% were treated with atypical drugs, 45.5% were treated with ECT 
and drugs. The difference between the two groups was statistically significant 
(P< .05).   
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TABLE NO.17 
CORRELATION OF DUP WITH IMPROVEMENT AT 8 WEEKS 
Variable Correlation coefficient P value 
Log DUP −0.3999 0.001 
PSA Total −0.4132 0.001 
 
The correlation between duration of untreated psychosis and premorbid 
functioning with improvement at 8 weeks is statistically significant (P<.05). 
TABLE NO.18 
PARTIAL CORRELATION OF DUP WITH IMPROVEMENT AT 8 WEEKS 
CONTROLLING FOR THE CONFOUNDING FACTORS SUCH AS AGE, 
AGE AT ONSET, SYMPTOMS AT BASELINE, AND PREMORBID 
FUNCTIONING 
 
Improved Correlation coefficient P value 
LogDUP −0.1794 .186 
 
The correlation of DUP with improvement after controlling for 
confounding factors is not significant (P>.05) 
TABLE NO.19 
PARTIAL CORRELATION OF PREMORBID FUNCTIONING WITH 
IMPROVEMENT AT WEEKS AFTER CONTROLLING FOR AGE, AGE AT 
ONSET DUP AND SYMPTOMS AT BASELINE 
Improved Correlation 
coefficient 
P value 
PSA Total score −0.1802 .184 
 
The correlation of premorbid social adjustment with improvement after 
controlling for confounding factors is not significant (P>.05). 
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DISCUSSION 
Studies state that a long duration of untreated psychosis confers a poor 
prognosis in schizophrenia. 
 Socio-demographic variables and DUP:     
The mean duration of untreated psychosis for the whole sample is 22.3 
months which is longer than the DUP reported in studies done in western 
countries. But mean DUP in this study is shorter when compared to some of the 
Indian studies (4 years in a study by Philip et al, 11.64 years in a study by 
padmavathi et al and more than 5 years by Tirupati et al). Among the whole 
sample 34% had a DUP greater than two years with 4 patients having a DUP 
greater than 8 years which again confirms the finding that patients in 
developing countries come late to treatment (Isaac et al, Thara et al). 
The role of socio-demographic variables in determining the duration of 
untreated psychosis has given contrasting results across various studies. Studies 
have shown that males have a longer DUP than females but we could not 
establish any such difference in gender to be associated with DUP. Numerous 
studies have not reported any relation of DUP with gender. 
The finding of a significant positive correlation of DUP with the age at 
first presentation shows that the duration of untreated psychosis increases as 
the age at first presentation to treatment increases, the result being similar to 
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the findings of Padmavathi et al that never treated patients were older in age 
and ill for a longer duration and were more symptomatic and severely disabled. 
This finding is in contrary to other studies that have not found a association 
between age and DUP.      
There is no significant correlation of duration of untreated psychosis 
with the educational level, marital status and socioeconomic status at baseline 
assessment, a finding which is similar to most other studies. One study in India 
has reported that untreated patients were most often uneducated and divorced 
and such a finding is not found in our study. In our study we found no 
correlation between DUP and employment, a finding contrary to the report of 
Morgan et al that unemployment has a less strong effect on duration of 
untreated psychosis. 
Some of the Indian studies have reported that a longer duration of 
untreated illness in schizophrenic patients was due to the larger extended/ joint 
family, which was able to compensate and cope with the dysfunctional 
member, concluding that such family system seemed to be a crucial factor 
related to the delay in treatment. In our study, though 70% of the patients were 
in the joint family system, there was no significant correlation of family type 
with DUP. In the West London first-episode study of schizophrenia, most of 
the patients were living alone or homeless. However, this study carried out in a 
Government Institute has its limitations regarding demographic variables like 
educational status, socioeconomic status and employment.      
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Clinical variables and DUP  
There is no significant association between the subtypes of 
schizophrenia with the duration of untreated psychosis at baseline assessment. 
Only few studies have studied the relation of diagnostic subtypes with DUP 
and have not found any significant association. 
In our study premorbid functioning is found to have a positive 
correlation with duration of untreated psychosis, showing that poor premorbid 
functioning is associated with a longer DUP than those with a better premorbid 
functioning, This finding is similar to the studies done by Verdoux et al and 
Malla et al where they have reported that poor premorbid functioning is 
associated with a long DUP and poor outcome. Some of the studies have not 
shown any such association between DUP and premorbid functioning.  
The correlation of DUP with symptom severity at baseline in this study 
has found a significant positive correlation with negative symptoms, but not 
with the disorganization and psychotic symptom domain. This finding is 
similar to the studies that have found a longer DUP to be associated with higher 
levels of negative or deficit symptoms at first presentation (Perkins et al). The 
negative correlation of DUP with psychotic symptom domain in the study, 
though not significant implies that schizophrenic patients with positive 
symptoms seek treatment earlier and hence have a shorter duration of untreated 
psychosis. Drake et al reported that longer DUP was associated with higher 
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positive symptoms at presentation which is not found in our study. Some of the 
studies do not find any such association between DUP and baseline symptoms 
(Loebel et al, Haas et al, Harris et al)   
The total number of patients at 8 weeks assessment is 63(65%) and the 
follow up rate is considerably lower when compared to most other studies, both 
Indian and studies done in western countries. The poor attrition rate could not 
be explained by any of the socio-demographic and clinical variables and the 
duration of untreated psychosis, a finding similar to the study done by Harris 
where they compared between those who completed follow up and those who 
did not. Information regarding the reasons for dropout was not available as 
those patients and their relatives could not be traced by any means. 
In the follow up assessment there is no significant difference between 
the improved and the unimproved group of patients on any of the socio-
demographic variables such as education, socio-economic status, marital status, 
employment and family type. This is in contrary to the studies that have shown 
that being married has a good outcome. 
There is no significant association between the two groups by age, age at 
onset of illness which is contrary to the finding of Perkins et al that younger 
age at onset predicts a poor prognosis and is a potential confounding factor of 
DUP and outcome.     
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DUP and outcome at 8 weeks 
There is a statistically significant difference between the improved and 
the unimproved groups on the duration of untreated psychosis, as the mean 
DUP for the improved group is 7.92 months and 22.78 months for the 
unimproved group of patients. This finding is similar to other studies that 
shorter DUP is associated with good outcome and treatment response than 
those with a longer DUP. In a study done by Philip et al, reported that patients 
with a short DUP have shown improvement at the end of 6 weeks following 
treatment. There have been contrasting reports that DUP has an influence on 
the outcome in the short term but not on the long term. Drake et al in his study 
concluded that DUP’s relationship to outcome is strongest in the initial months 
of psychosis and has implications for targeting early intervention. 
The subtype of schizophrenia did not show any significant difference 
between the improved and the unimproved groups though paranoid 
schizophrenia is the most common diagnosis in the sample. 
In this study there is no difference among the two groups by family 
history suggestive of schizophrenia in 1st or 2nd degree relatives.    
The duration of hospitalization between the two groups was not 
significant as more than 80% of the patients were hospitalized for less than two 
weeks. This finding is similar to the report of Haas et al that there is no 
significant difference in terms of duration of hospitalization between the long 
and short DUP groups. 
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Treatment response 
The mode of treatment between the two groups is statistically significant 
as 78% of the improved group were treated with atypical antipsychotics and 
54.5% among the unimproved group with atypicals. This difference could be 
explained by the fact that patients with a shorter DUP would have had a better 
response to treatment as described by Perkins et al in his study. This result has 
to be interpreted with caution as the type of drugs, dosage, and adequacy of 
dose was not included in our study. Few studies differ as Barnes et al found 
that there was little evidence of any association between dup and the 
development of resistance to initial drug treatment.  
In our study the premorbid social adjustment score is statistically 
significant between the improved and the unimproved groups, indicating that 
poor premorbid functioning is associated with poor improvement. This finding 
is similar to the reports of Verdoux et al that premorbid functioning is an 
important predictor of outcome. Again the premorbid Social Adjustment scale 
used in this study assesses premorbid functioning in social and school 
activities, for which 11.34% of the sample in our study were uneducated 
making it difficult to assess in these group of patients. 
Confounding factors, DUP and outcome 
In order to find the relationship of confounding factors associated with 
DUP and outcome, a partial correlation was done controlling for the 
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confounding factors such as age, age at onset of illness, symptom domains of 
psychotic, disorganized and negativism and premorbid functioning. The 
correlation found that DUP is not statistically significant after controlling for 
the confounding factors, as unadjusted DUP explained for 39% of variance in 
the outcome which decreased by 17% after adjusting for the confounding 
factors. This finding that duration of untreated psychosis is not an independent 
predictor of outcome is in contrary to most of the studies that reported DUP to 
be significant predictor of outcome after controlling for the confounding 
factors. 
As premorbid functioning has shown a statistically significant 
correlation with improvement at 8 weeks, we did a partial correlation 
controlling for the confounding factors and found that premorbid functioning is 
not statistically significant. This finding is similar to studies that report 
premorbid functioning is not a strong predictor of outcome and the observed 
association between DUP and outcome was not explained by premorbid 
adjustment. 
Thus in our study we found that duration of untreated psychosis is not 
an independent predictor of outcome and is confounded by variables such as 
premorbid functioning, mode of treatment and other variables suggesting that 
duration of untreated psychosis alone is not a predictor of short term outcome. 
 60
SUMMARY AND CONCLUSION 
The aim of this study is to find the social and clinical determinants of 
duration of untreated psychosis, the influence of duration of untreated  
psychosis on short-term outcome and the relationship of premorbid functioning 
on duration of untreated psychosis and outcome in a sample of drug-naïve 
schizophrenia patients diagnosed according to the ICD-10. Strict inclusion and 
exclusion criteria’s were used to get a homogenous sample. 
100 patients were selected for the study of which 97 were assessed at 
baseline with SAPS and SANS for psychopathology, PSA scale to assess 
premorbid functioning, duration of untreated psychosis and a socio-
demographic profile were obtained. 63 patients were assessed at 8 weeks of 
follow up for psychopathology and categorized into improved and unimproved 
as per CGI-SCH and GAF scale. Correlation of DUP with socio-demographic, 
clinical and symptoms at baseline was done, comparison between the improved 
and the unimproved groups was done. The results were analyzed using chi-
square test, t-test, Pearson’s correlation and partial correlation.  
The study showed the following results 
1. Significant positive correlation between duration of untreated psychosis 
and the age at first presentation. 
2. Significant positive correlation between duration of untreated psychosis 
and negative symptoms at baseline. 
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3. Significant positive correlation between duration of untreated psychosis 
and premorbid functioning at baseline. 
4. Improved group of patients had a short duration of untreated psychosis 
than the unimproved group. 
5. Improved groups of patients had a better premorbid functioning than the 
unimproved group. 
6. Statistically significant difference between the improved and the 
unimproved groups by the mode of treatment. 
7. Statistically significant difference between the improved and the 
unimproved groups in the negative symptom domain. 
8. There is no significant correlation of duration of untreated psychosis and 
premorbid functioning with improvement after the confounding factors 
were controlled. 
The findings from this study suggest that a longer duration of untreated 
psychosis is associated with increased age at presentation, higher negative 
symptoms and poor premorbid functioning. The results show that improved 
patients have a short duration of untreated psychosis and better premorbid 
functioning than the unimproved patients but the association is not significant 
after the confounding factors were controlled. This finding concludes that 
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duration of untreated psychosis is not an independent predictor of outcome as 
stated in literature. 
It is conceivable that the reported better outcome for schizophrenia in 
India is unlikely to be because of shorter DUP. However, instituting treatment 
earlier gives further advantage and can make the outcome in our people even 
brighter. 
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LIMITATIONS 
1. Assessment of duration of untreated psychosis involves retrospective 
recall of time of onset of psychosis, which has the usual recall bias from 
the patient. 
2. As short term outcome was measured in this study the change in 
symptoms after 8 weeks could be more a measure of speed of recovery. 
3. Variables related to duration of untreated psychosis such as pathways to 
care, mode of onset, substance use were not included. 
4. Treatment details were not described in detail as it could have a 
significant influence on outcome. 
5. The researcher was not blind to the patients at the time of follow up 
assessment as literature says that there is a likely chance for bias in 
assessment. 
6. High attrition rate among the sample during follow up. 
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IMPLICATIONS 
Schizophrenia may involve a progressive pathological process that is 
well developed by the time the frank psychopathology of schizophrenia 
emerges. An association between duration of untreated psychosis and clinical 
outcome offers hope that early intervention programs that are effective in 
reducing the length of the initial psychotic episode may enhance the likelihood 
of recovery from a first episode of schizophrenia and perhaps reduce 
cumulative morbidity. Ameliorating the symptoms of initial psychosis may not 
only lessen the immediate suffering and burden of disease experienced by 
patients and their families, but it may also improve long-term prognosis by 
limiting progression of the illness and preserving a person’s ability to respond 
to antipsychotic medication. 
In future studies it will be particularly important to evaluate the effect of 
reduction of the duration of untreated psychosis on initial negative symptom 
severity and negative symptom response to treatment. From a public health 
perspective, it is of major importance to further investigate the links between 
duration of untreated psychosis, premorbid characteristics, outcome in large 
sample sizes and in studies aimed at assessing the impact of early identification 
and treatment of schizophrenia. 
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FUTURE DIRECTIONS 
Studies that advance our understanding of the mechanism responsible 
for the relationship of duration of psychosis and outcome will most likely 
provide critical information about the neuropathology of schizophrenia. The 
evidence for clinical deterioration after a prolonged period of initially untreated 
psychosis, manifested through the development of secondary resistance to 
antipsychotic treatment and progressive functional impairments, suggests that 
at least part of the clinical deterioration characteristic of schizophrenia is 
mediated by a progressive pathophysiological process. Longitudinal studies, 
especially those that to attempt to look at change in brain structure and function 
beginning at the premorbid and prodromal stage of illness and extending 
through the first episode, are likely to increase our understanding of the nature 
and timing of the neurochemical, neuroanatomical, and clinical pathways that 
underlie clinical deterioration in schizophrenia. 
Another important issue relates to the observation of treatment 
resistance in individuals with a DUP as short as 4 weeks, as well as preserved 
responsiveness to antipsychotic treatment with DUP longer than 5 years. 
Variability in treatment responsiveness may reflect fundamentally different 
neurobiological process involved in the development and progression of 
symptoms. The potential protective factors that may contribute to the 
preservation of treatment responsiveness and to improved clinical outcome in 
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patients with a long DUP merit further attention, as they may lead to discovery 
of new therapeutic medications.  
At the end of this study we suggest that the future studies include 
variables such as recognition of illness, access to and availability of care, 
stigma, perinatal complications and neurological soft signs. 
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APPENDIX-I 
PROFORMA 
 
Name: 
Age: 
Sex: 
Education: Uneducated/ Primary/ High school/ Secondary/ Graduate 
Occupation: Employed/ Unemployed 
Socio-economic status: Low/ Middle/ High 
Marital status: Married/ Separated/ Divorced/ Widow/ Unmarried 
Type of family: Nuclear/ Joint 
Family history: Yes/ No 
Age at onset: 
Diagnosis: Paranoid/ Hebephrenic/ Catatonic/ Undifferentiated/ Simple 
Duration of Untreated Psychosis (months): 
Duration of Untreated Psychosis: 1-6mon/ 7-12mon/ 13-18mon/ 19-24mon/                               
                                                      >24months 
Duration of Hospitalization: <7days/ 8-24days/ 15-21days/ 22-28 days 
Mode of treatment: Typical antipsychotics/ Atypicals/ ECT 
 
APPENDIX - II 
 
Scale for Assessment of Positive Symptoms (SAPS) 
 
Hallucinations 
1) Auditory Hallucinations:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
2) Voices Commenting:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
3) Voices Conversing:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
4) Somatic or Tactile Hallucinations:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
5) Olfactory Hallucinations:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
6) Visual Hallucinations:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
7) Global Rating of Hallucinations:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
Delusions  
8)   Persecutory Delusions:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
9)   Delusions of jealousy:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
10) Delusions of Guilt or Sin:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
11) Grandiose Delusions:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
12) Religious Delusions:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
13) Somatic Delusions:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
14) Delusions of Reference:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
15) Delusions of Being Controlled:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
16) Delusions of Mind Reading:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
17) Thought Broadcast:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
18) Thought Insertion:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
19) Thought Withdrawal:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
20) Global Rating of Delusions:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
Bizarre Behavior 
21) Clothing and Appearance:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
22) Social and Sexual Behavior:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
23) Aggressive and Agitated Behavior:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
24) Repetitive or Stereotyped Behavior:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
25) Global Rating of Bizarre Behavior:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
Positive Formal Thought Disorder 
26) Derailment:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
27) Tangentiality:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
28) Incoherence:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
29) Illogicality:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
30) Circumstantiality:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
31) Pressure of Speech:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
32) Distractible Speech:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
33) Clanging:       0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
34) Global Rating of Formal Thought Disorder:  0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
Inappropriate Affect  
35) Inappropriate Affect:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
 
Total Psychoticism Score    : _______ 
 
Total Disorganization Score: _______ 
 
0 = None; 1 = Questionable; 2 = Mild; 3 = Moderate; 4 = Marked; 5 = Severe 
 
APPENDIX - III 
 
Scale for Assessment of Negative Symptoms (SANS) 
 
Affective Flattening or Blunting 
1) Unchanging Facial Expression:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
2) Decreased Spontaneous Movements:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
3) Paucity of Expressive Gestures:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
4) Poor Eye Contact:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
5) Affective Non-responsivity:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
6) Lack of Vocal Inflections:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
7) Global Rating of Affective Flattening:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
 
Alogia 
8) Poverty of Speech:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
9) Poverty of Content of Thought:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
10) Blocking:       0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
11) Increased Latency of Response:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
12) Global Rating of Alogia:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
 
Avolition – Apathy 
13) Grooming and Hygiene:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
14) Impersistence at Work or School:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
15) Physical Anergia:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
16) Global Rating of Avolition – Apathy:  0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
 
Anhedonia – Asociality 
17) Recreational Interests and Activities:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
18) Sexual Activity:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
19) Ability to Feel Intimacy and Closeness:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
20) Relationships with Friends and Peers:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
21) Global rating of Anhedonia – Asociality:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
 
Attention 
22) Social Inattentiveness:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
23) Inattentiveness during Mental Testing:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
24) Global Rating of Attention:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
 
TOTAL NEGATIVE SYMPTOM SCORE: __________ 
 
0 = None; 1 = Questionable; 2 = Mild; 3 = Moderate; 4 = Marked;  
5 = Severe 
 
 
 
APPENDIX - IV 
 
CLINICAL GLOBAL IMPRESSION – SCHIZOPHRENIA SCALE 
 
I. Severity of illness 
Considering your total clinical experience with patients with 
schizophrenia, how severely ill has the patient been during the last week? 
The following symptoms were assessed. 
1. Positive symptoms (e.g. hallucinations, delusions or bizarre behavior) 
2. Negative symptoms (e.g. affective flattening, avolition or anhedonia) 
3. Depressive symptoms (e.g. . sadness, depressed mood or hopelessness) 
4. Cognitive symptoms (e.g. impaired attention, concentration or memory) 
5. Overall severity 
Rating of severity 
1. Normal, not ill 
2. Minimally ill 
3. Mildly ill 
4. Moderately ill 
5. Markedly ill 
6. Severely ill 
7. Among the most severely ill 
 
1I. Degree of change 
Compared to the previous evaluation*, how much has the patient 
changed? Rate improvement whether or not, in your judgement, is due entirely 
to treatment? 
       1. Very much improved 
       2. Much improved 
       3. Minimally improved 
       4. No change 
       5. Minimally worse 
       6. Much worse 
       7. Very much worse 
 
APPENDIX - V 
 
PREMORBID SOCIAL ADJUSTMENT SCALE 
 
Standardized entry questions are used for each item. Scoring is on a scale 
from 1 to 7 for each of the five items. Each item is scored separately for 
childhood (5-11years) and adolescence (12-16 years) and total score is pbtained 
by adding the two. 
1. Sociability and isolation. 
1. Not withdrawn, active social interaction 
3. Mild withdrawl, enjoyed socialization when involved- 
occasionally sought opportunities to socialize  
5. Moderately withdrawn, given to daydreaming and excessive 
fantasy,  did not seek contact 
7. Unrelated to others, isolated, avoided contacts 
2.   Peer relations. 
1. Many friends, close relationships   
3. Casual friends only 
5. Deviant friendship patterns: only friends with children older or  
younger 
7. Socially isolated, not even superficial relationships 
3. Scholastic performance 
1. Excellent student, top of class 
3. Average student 
5.  Failing all classes 
7. Required special education  
 
1. Adaptation to school   
1. Good adaptation, enjoyed school, no discipline problems  
3. Fair adaptation, occasional discipline problems, not very  
 interested in school 
5. Poor adaptation, disliked school, frequent truancy and discipline 
problems 
7. Refused to have anything to do with school- delinquency or 
vandalism directed against school 
2. Interests 
1. Active, involved in a range of school, sporting and social 
activities  and hobbies 
3. Involved in one school, sporting, or social activity with other 
younger people 
5. Introverted interests- one or a few hobbies which required no 
contact with others 
7. No interests- withdrawn and indifferent toward interests of the 
average youngster 
 
APPENDIX - VI 
 
GLOBAL ASSESSMENT OF FUNCTIONING SCALE 
 
Consider psychological, social, and occupational functioning on a 
hypothetical continuum of mental health illness. Do not include impairment in 
functioning due to physical or environmental limitations. 
91-100 Superior functioning in a wide range of activities, life’s 
problems never seem to get out of hand, is sort out by others because of his or 
her positive qualities. No symptoms. 
81-90 Absence or minimal symptoms, good functioning in all areas, 
interested and involved in a wide range of activities, socially effective, 
generally satisfied with life, no more than every day problems or 
concerns.(e.g., an occasional argument with family members.) 
71-80 If symptoms are present they are transient and expectable 
reactions to psycho social stressors: no more than slight impairment in social, 
occupational or school functioning. (Temporarily falling behind in school 
work). 
61-70 Some mild symptoms(e.g. depressed mood and mild insomnia) 
OR some difficulty in social, occupational, school functioning, but generally 
functioning pretty well, has some meaningful interpersonal relationships. 
51-60 Moderate symptoms (e.g. flat affect and circumstantial speech, 
occasional panic attacks) OR moderate difficulty in school, occupational or 
social functioning. (e.g. few friends, conflicts with peers or co-workers) 
41-50 Serious symptoms (e.g. suicidal ideation, severe obsessional 
rituals, frequent shop lifting) OR any serious impairment in social, 
occupational or school functioning ( e.g. No friends, unable to keep a job). 
 
31-40 Some impairment in reality testing or communication ( e.g. 
speech is at times illogical, obscure, or irrelevant) OR major impairment in 
several areas of life such as school, family relations, judgement, thinking or 
mood( depressed man avoids friends, neglects family and is unable to work; 
child frequently beats up younger children and is defiant at home, and is failing 
at school). 
21-30 Behavior is considerably influenced by delusions or 
hallucinations OR serious impairment in communication or judgement (e.g. 
sometimes incoherent, acts grossly inappropriately, suicidal preoccupation) OR 
inability to function in almost all areas (stays in bed almost all the day; no job, 
home or friends). 
11-20 Some danger of hurting self or others (suicidal attempts without 
clear expectation of death, frequently violent, manic excitement) or 
occasionally fails to maintain personal hygiene OR gross impairment in 
communication (e.g. largely coherent or mute). 
1-10 Persistent danger of severely hurting self or pothers (recurrent 
violence) OR persistent inability to maintain minimal personal hygiene OR 
serious suicidal act with clear expectation of death.  
 
 
